User profiles for Jeffrey Drazen
Jeffrey M. DrazenProfessor, Harvard Medical School Verified email at nejm.org Cited by 73908 |
Global strategy for asthma management and prevention: GINA executive summary
Asthma is a serious health problem throughout the world. During the past two decades, many
scientific advances have improved our understanding of asthma and ability to manage and …
scientific advances have improved our understanding of asthma and ability to manage and …
Clinical trial registration: a statement from the International Committee of Medical Journal Editors
C De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey… - The Lancet, 2004 - thelancet.com
In today’s Lancet, the INTERHEART study investigators report a well-coordinated study of
risk factors for myocardial infarction in multiple populations. They present hazard ratios and …
risk factors for myocardial infarction in multiple populations. They present hazard ratios and …
Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes
The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …
updated evidence-based strategy for asthma management and prevention, which can be …
Artificial intelligence and machine learning in clinical medicine, 2023
CJ Haug, JM Drazen - New England Journal of Medicine, 2023 - Mass Medical Soc
AI and Machine Learning in Clinical Medicine, 2023 This first article in a series describes the
history of artificial intelligence in medicine; the use of AI in image analysis, identification of …
history of artificial intelligence in medicine; the use of AI in image analysis, identification of …
[HTML][HTML] Statistics in medicine—reporting of subgroup analyses in clinical trials
The analysis of subgroups is often used as a way to glean additional information from data
sets. The strengths and weaknesses of this approach and new Journal policies concerning …
sets. The strengths and weaknesses of this approach and new Journal policies concerning …
The biology of nitrogen oxides in the airways.
Nitrogen oxides (NOx), regarded in the past primarily as toxic air pollutants, have recently
been shown to be bioactive species formed endogenously in the human lung. The relationship …
been shown to be bioactive species formed endogenously in the human lung. The relationship …
Treatment of asthma with drugs modifying the leukotriene pathway
In 1979 and 1980, the chemical structures of the material previously known as slow-reacting
substance of anaphylaxis were elucidated as 5(S)- hydroxy- 6(R)-glutathionyl- 7,9-trans-11,…
substance of anaphylaxis were elucidated as 5(S)- hydroxy- 6(R)-glutathionyl- 7,9-trans-11,…
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic
groups and countries. It is estimated that around 250,000 people die prematurely each year …
groups and countries. It is estimated that around 250,000 people die prematurely each year …
A summary of the new GINA strategy: a roadmap to asthma control
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …
annually updated a global strategy for asthma management and prevention that has formed …
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet
Human asthma is associated with airway infiltration by T helper 2 (T H 2) lymphocytes. We
observed reduced expression of the T H 1 transcription factor, T-bet, in T cells from airways of …
observed reduced expression of the T H 1 transcription factor, T-bet, in T cells from airways of …